Heart Failure Drug Candidate Triggers Growth Hormone Surge in New Trial

Researchers found that infusing acyl ghrelin—a naturally occurring hormone—increased growth hormone levels in heart failure patients with weakened pumping capacity. The finding suggests a potential new therapeutic pathway for a condition affecting millions globally, opening a drug development opportunity in the underserved heart failure market.

Originaltitel: Acyl ghrelin infusion increases circulating growth hormone in patients with heart failure and reduced ejection fraction